Hamburg

UKE's new prostate cancer centre to launch in 2024

13 November 2023
UKE to open newly built Martini Clinic featuring outpatient chemotherapy and eight operating theatres

The University Hospital Hamburg-Eppendorf (UKE) is gearing up to open its new prostate cancer in the Martini Clinic in Q2 of 2024 now that construction, underway since 2019, has ended at a cost of EUR 86 million. The new centre features cutting-edge technology, four wards and 100 beds to treat even more prostate cancer patients from early diagnosis through to advanced stages of the disease.

Martini-Klinik to offer innovative surgical and treatment concepts

"The treatment of prostate cancer has developed rapidly over the past three decades, and the Martini Clinic has made a major contribution to this with pioneering medicine and care as well as innovative surgical and treatment concepts," said Prof. Dr. Christian Gerloff, Board Member of UKE. The clinic offers new treatment rooms e.g., for outpatient chemotherapy while eight operating theatres will be equipped with robot-assisted operating systems and focal therapy techniques.

UKE responding to high demand for prostate cancer treatment

"The Martini Clinic is the world's number one treatment and research centre of prostate cancer," said Katharina Fegebank, Deputy Mayor of Hamburg . Around 5,000 outpatients and 2,700 inpatients will be treated in the Martini Clinic every year.  An increasing number of patients have been treated in Germany and abroad in recent years, according to Dr. Detlef Loppow, Managing Director of the Martini Clinic. Data from the Federal Statistical Office indicates that the group of 50 to 70-year-olds will comprise more than 10.7 million men by 2040. "For this reason, we and the Executive Board of UKE decided in 2015 in favour of a new building with significantly more beds and operating theatre capacity," he pointed out.
fw/mm/pb

Sources and further information

Similar articles

UKE's emergency practice relieving emergency department

Survey finds practice relieving patients and emergency department - possible, cost-saving alternative

UKE managing international "GUIDE.MRD" research into cancer

Consortium researching use of liquid biopsies against residual tumor cells - EUR 3.4 million for UKE

AI's impact on medicine

SERIES (4): Alexander T. El Gammal working on an AI-based clinical assistant - portrait of a medical visionary

Beiersdorf and DKFZ invest EUR 4.6 million in skin cancer prevention

New joint innovation lab aims to reverse biological ageing of skin cells
The Consent Management Platform (https://app.usercentrics.eu/) we use could not be loaded. This can happen if AdBlockers incorrectly block this URL. Some features such as maps, proximity search or forms, cannot be used this way. To use these features, please deactivate your AdBlocker or allow access to *.usercentrics.eu.